Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

129 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Subtype-specific KRAS mutations in advanced lung adenocarcinoma: a retrospective study of patients treated with platinum-based chemotherapy.
Cserepes M, Ostoros G, Lohinai Z, Raso E, Barbai T, Timar J, Rozsas A, Moldvay J, Kovalszky I, Fabian K, Gyulai M, Ghanim B, Laszlo V, Klikovits T, Hoda MA, Grusch M, Berger W, Klepetko W, Hegedus B, Dome B. Cserepes M, et al. Among authors: fabian k. Eur J Cancer. 2014 Jul;50(10):1819-1828. doi: 10.1016/j.ejca.2014.04.001. Epub 2014 Apr 22. Eur J Cancer. 2014. PMID: 24768329 Free article.
Lung cancer drug therapy in Hungary - 3-year experience.
Moldvay J, Rokszin G, Abonyi-Tóth Z, Katona L, Fábián K, Kovács G. Moldvay J, et al. Among authors: fabian k. Onco Targets Ther. 2015 May 13;8:1031-8. doi: 10.2147/OTT.S65794. eCollection 2015. Onco Targets Ther. 2015. PMID: 25999737 Free PMC article.
[Excerpts from the collaborative lung cancer research program of Semmelweis University, the National Institute of Oncology and Korányi Institute of TB and Pulmonology (2010-2015)].
Hegedûs B, Moldvay J, Berta J, Lohinai Z, Rózsás A, Cserepes MT, Fábián K, Ostoros G, Tóvári J, Rényi-Vámos F, Tímár J, Döme B. Hegedûs B, et al. Among authors: fabian k. Magy Onkol. 2015 Dec;59(4):282-5. Epub 2015 Nov 21. Magy Onkol. 2015. PMID: 26665187 Free article. Hungarian.
KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis.
Lohinai Z, Klikovits T, Moldvay J, Ostoros G, Raso E, Timar J, Fabian K, Kovalszky I, Kenessey I, Aigner C, Renyi-Vamos F, Klepetko W, Dome B, Hegedus B. Lohinai Z, et al. Among authors: fabian k. Sci Rep. 2017 Jan 4;7:39721. doi: 10.1038/srep39721. Sci Rep. 2017. PMID: 28051122 Free PMC article.
129 results